The phase 3 vaccines of the Chinese company CanSino Biologics that will arrive in Mexico will be distributed in 14 states, five of these are among those that report the highest number of infections and deaths from COVID-19.
The 14 states of the country that will receive the vaccines to test the effectiveness and safety of the vaccine are Aguascalientes, Mexico City, Chihuahua, Durango, Guerrero, Hidalgo, Jalisco, Michoacán, Morelos, Nuevo León, Oaxaca, Puebla, Quintana Roo and Veracruz .
Of these entities, at least eight are in the midst of a rebound in infections, such as Chihuahua, which has a hospital occupancy close to 90% in general beds and 65% in beds with ventilators; Durango also returned to a red light. Mexico City, Hidalgo, Jalisco and Nuevo León are among the states with increases in the numbers of COVID positives, as well as in hospitalization figures.
In contrast, six states in which the doses will also be applied among volunteers maintain the decrease in hospitalized people and deaths: Morelos, Puebla, Quintana Roo, Veracruz, Michoacán and Oaxaca.
Yesterday, Foreign Minister Marcelo Ebrard said that on October 30, the first doses of the vaccine were received from the Chinese company CanSino Biologics, in order to conduct phase 3 clinical trials.
“After a rigorous evaluation process by Cofepris and the Ministry of Health, it was approved that the studies be carried out in groups of between 10 and 15 thousand Mexican volunteers over 18 years old,” he said. The vaccine will be tested in 20 hospitals in various entities.
The governor of San Luis Potosí and president of the National Conference of Governors (Conago), Juan Manuel Carreras López (PRI), reported that on Monday, Foreign Minister Ebrard informed them that Mexico will be the first country in Latin America to participate in this trial Global Phase III from CanSino Biologics.
92 THOUSAND DECESTS ARE
On the national scene, the Ssa reported last night that Mexico accounted for 92 thousand 593 deaths from COVID-19, 493 more than last Monday, as well as an accumulated 938 thousand 405 infections, an increase of 5 thousand 250 compared to the previous day.
At a press conference, José Luis Alomía, director of Epidemiology, pointed out that the active epidemic, that is, people who can still transmit the virus, is made up of 42,725 patients. He added that the positivity rate is 39%.